REGULAR ASPIRIN USE DOES NOT REDUCE RISK OF COGNITIVE DECLINE
Creators
Brendan J. Kelley - The Ohio State University
Leslie A. McClure - University of Alabama at Birmingham
Frederick W. Unverzagt - Indiana University – Purdue University Indianapolis
Brett Kissela - University of Cincinnati
Dawn Kleindorfer - University of Cincinnati
George Howard - University of Alabama at Birmingham
Virginia G. Wadley - University of Alabama at Birmingham
Publication Details
Journal of the American Geriatrics Society (JAGS), v 63(2), pp 390-392
Publisher
Wiley
Number of pages
3
Grant note
U01 NS041588 / National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH), Department of Health and Human Service
UL1TR001425 / NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)
U01NS041588 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
Resource Type
Journal article
Language
English
Academic Unit
Epidemiology and Biostatistics
Web of Science ID
WOS:000349893300030
Scopus ID
2-s2.0-84923259871
Other Identifier
991019231650304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: